In order to achieve this, the European Commission has consistently advocated a policy of "tiered pricing" for medicines, combined with market segmentation between rich and poor countries.
Para lograrlo, la Comisión Europea ha defendido siempre una política de «precios diferenciados» para los medicamentos, combinada con una segmentación del mercado entre países ricos y pobres.